Philippe Boulette-Scola, manager of Infiplast in Oyonnax in the French “Plastic Valley”, has reduced the company’s presence in the automobile sector to below 33% and is now making headway in the medical sector. “A tricky step to make”, he admits, two years after launching Luponax, a division specialising in added-value parts such as implantable chambers and polysulphone components. “Manufacturers in the medical sector enforce strict hygiene and safety checks. You can count on at least three years of hard effort before being accepted as one of their suppliers.” The plastics expert is also putting his money on developing the building activity. In one year, his sales have progressed from 3 to 12%. “These two markets push us to innovate, increase our capacity and study new design methods. Infiplast intends to become a designer of complete sub-assemblies in partnership with its customers”, he adds.“ |
